Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones (Q36288667)

13 August 2017

3 references

23 March 2019

4 August 2019

7 December 2020

0 references

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones (English)

1 reference

respiratory tract infection

13 August 2017

1 reference

4 August 2019

1 reference

4 August 2019

1 reference

7 December 2020

Marieke J. Van Der Werf

Marieke J van der Werf

8

0 references

Rosella Centis

Rosella Centis

Giovanni Battista Migliori

4

0 references

Giovanni Battista Migliori

1

0 references

Francesco Blasi

Francesco Blasi

5

0 references

Miranda Langendam

2

Miranda W Langendam

1 reference

13 August 2017

Lia D'Ambrosio

3

1 reference

13 August 2017

Emma Huitric

6

1 reference

13 August 2017

Davide Manissero

7

1 reference

13 August 2017

31 May 2012

1 reference

European Respiratory Journal

13 August 2017

1 October 2012

3 references

23 March 2019

4 August 2019

7 December 2020

4 references

13 August 2017

23 March 2019

4 August 2019

7 December 2020

40

1 reference

13 August 2017

4

1 reference

13 August 2017

814-822

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

13 August 2017

3 references

23 March 2019

4 August 2019

European union standards for tuberculosis care

7 December 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Guidelines for the management of adult lower respiratory tract infections--full version

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

The WHO policy package to combat antimicrobial resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Global tuberculosis drug development pipeline: the need and the reality.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

First tuberculosis cases in Italy resistant to all tested drugs.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Guidelines for the management of adult lower respiratory tract infections

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

The diagnosis and therapy of tuberculosis during the past 100 years

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculo

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Impact of short-term exposure to fluoroquinolones on ofloxacin resistance in HIV-negative patients with tuberculosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Childhood tuberculosis: progress requires an advocacy strategy now.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009).

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Towards the development of EU/EEA Standards for Tuberculosis Care (ESTC).

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Preventing and managing antimicrobial resistance: imperative for chest physicians.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Extensively drug-resistant tuberculosis: back to the future.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Fluoroquinolone Resistance in Patients with Newly Diagnosed Tuberculosis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

5 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Finding the way through the respiratory symptoms jungle: PAL can help: Respiratory Infections Assembly contribution to the celebration of 20 years of the ERS

5 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Clinical and operational value of the extensively drug-resistant tuberculosis definition

5 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461345

Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22653774

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1183/09031936.00036812

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

22653774

1 reference